首页> 美国卫生研究院文献>Springer Open Choice >Measurement of 131I activity in thyroid of nuclear medical staff and internal dose assessment in a Polish nuclear medical hospital
【2h】

Measurement of 131I activity in thyroid of nuclear medical staff and internal dose assessment in a Polish nuclear medical hospital

机译:波兰核医学医院核医学人员甲状腺中131I活性的测定和内部剂量评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper presents results of 131I thyroid activity measurements in 30 members of the nuclear medicine personnel of the Department of Endocrinology and Nuclear Medicine Holy Cross Cancer Centre in Kielce, Poland. A whole-body spectrometer equipped with two semiconductor gamma radiation detectors served as the basic research instrument. In ten out of 30 examined staff members, the determined 131I activity was found to be above the detection limit (DL = 5 Bq of 131I in the thyroid). The measured activities ranged from (5 ± 2) Bq to (217 ± 56) Bq. The highest activities in thyroids were detected for technical and cleaning personnel, whereas the lowest values were recorded for medical doctors. Having measured the activities, an attempt has been made to estimate the corresponding annual effective doses, which were found to range from 0.02 to 0.8 mSv. The highest annual equivalent doses have been found for thyroid, ranging from 0.4 to 15.4 mSv, detected for a cleaner and a technician, respectively. The maximum estimated effective dose corresponds to 32% of the annual background dose in Poland, and to circa 4% of the annual limit for the effective dose due to occupational exposure of 20 mSv per year, which is in compliance with the value recommended by the International Commission on Radiological Protection.
机译:本文介绍了波兰Kielce内分泌和核医学系圣十字癌症中心30名核医学人员的 131 I甲状腺活性测量结果。配备有两个半导体伽马射线探测器的全身光谱仪是基础研究仪器。在30名接受检查的工作人员中,有十名发现所确定的 131 I活性高于检出限(甲状腺中 131 I的DL = 5 Bq)。测得的活动范围为(5±2)Bq至(217±56)Bq。技术人员和清洁人员的甲状腺活动最高,而医生的活动最低。测量活动后,已尝试估算相应的年度有效剂量,发现其范围为0.02至0.8 mSv。已发现清洁剂和技术人员的甲状腺年度最高当量剂量分别为0.4至15.4 mSv。估计的最大有效剂量相当于波兰年度背景剂量的32%,并且由于每年20 mSv的职业暴露而导致的有效剂量年度上限约为4%,这符合欧盟建议的值国际放射防护委员会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号